This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Authentidate Trading Volume Spikes

Authentidate (ADAT) shares are on the move, with volume almost five times higher than normal.

More than 760,000 shares have traded today, while the three-month average is around 160,000 shares. Authentidate is a New Jersey-based company that provides health information exchange solutions. This means that physicians can use their software for workflow management, making their medical records electronic. They also have solutions in patient discharge and telehealth devices. There are a few recent developments that might be playing a role in Authentidate's activity.

* In December, they raised $3.4M of capital. They issued 3.4M common shares, along with 3.4M 90-day warrants at a $1 strike. This volume requires sellers, and it's very likely the warrants are now being exercised.

* As of the last quarterly call, we learned that their Liberty contract for Inscrybe solutions is back again. Liberty's contract significantly impacts their financial results and had ended. In the past, it was a customized solution, however now it's the standard software.

* Authentidate's 2010 fiscal year began July 1, 2009. This means that we are now in the second half of fiscal 2010. From their January Investor Presentation file (, you can see this on Page 14: "Initial sales for the telehealth and hospital discharge solutions are expected in the second half of fiscal 2010."

* Telehealth devices have been around for a while - Bosch has been in the market for 10 years, and now we're seeing more competition. Intel (INTC - Get Report) and GE (GE - Get Report) are in the market. Intel and GE recently pushed their partnership from just the United States into the United Kingdom.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ADAT $3.16 -5.11%
CERN $53.53 -3.90%
GE $29.84 -0.76%
INTC $29.89 0.13%
MDRX $13.38 0.38%


Chart of I:DJI
DOW 17,596.89 -63.82 -0.36%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs